technology prnewswire_all 7/15/2026 1 views

CellCarta Launches Digital Pathology and AI Consortium to Accelerate Platform-Agnostic Biomarker Innovation Across Drug Development

Consortium initially brings together Lunit, Mindpeak, Imagene AI, Dipath AI, Nucleai, Tivenix and Indica Labs to give biopharma sponsors a single CRO-led, global AI-agnostic path to evaluate and apply digital pathology, image analysis, spatial biology and precision diagnostics...
Relevant beings: aiku.inwecharge.in
View original →